ACAP1
Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 1
Also known as: ACAP1_HUMAN, CENTB1, KIAA0050
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q15027
- Gene
- ACAP1
- Ensembl
- ENSG00000072818
- Chromosome
- 17
- Canonical length
- 740 aa
- Protein class
- Cancer-related genes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Golgi apparatus
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Predicted to enable GTPase activator activity and zinc ion binding activity. Predicted to be involved in protein transport. Located in membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
740 residues, UniProt reviewed canonical sequence.
>Q15027|ACAP1
1 MTVKLDFEEC LKDSPRFRAS IELVEAEVSE LETRLEKLLK LGTGLLESGR HYLAASRAFV
61 VGICDLARLG PPEPMMAECL EKFTVSLNHK LDSHAELLDA TQHTLQQQIQ TLVKEGLRGF
121 REARRDFWRG AESLEAALTH NAEVPRRRAQ EAEEAGAALR TARAGYRGRA LDYALQINVI
181 EDKRKFDIME FVLRLVEAQA THFQQGHEEL SRLSQYRKEL GAQLHQLVLN SAREKRDMEQ
241 RHVLLKQKEL GGEEPEPSLR EGPGGLVMEG HLFKRASNAF KTWSRRWFTI QSNQLVYQKK
301 YKDPVTVVVD DLRLCTVKLC PDSERRFCFE VVSTSKSCLL QADSERLLQL WVSAVQSSIA
361 SAFSQARLDD SPRGPGQGSG HLAIGSAATL GSGGMARGRE PGGVGHVVAQ VQSVDGNAQC
421 CDCREPAPEW ASINLGVTLC IQCSGIHRSL GVHFSKVRSL TLDSWEPELV KLMCELGNVI
481 INQIYEARVE AMAVKKPGPS CSRQEKEAWI HAKYVEKKFL TKLPEIRGRR GGRGRPRGQP
541 PVPPKPSIRP RPGSLRSKPE PPSEDLGSLH PGALLFRASG HPPSLPTMAD ALAHGADVNW
601 VNGGQDNATP LIQATAANSL LACEFLLQNG ANVNQADSAG RGPLHHATIL GHTGLACLFL
661 KRGADLGARD SEGRDPLTIA METANADIVT LLRLAKMREA EAAQGQAGDE TYLDIFRDFS
721 LMASDDPEKL SRRSHDLHTLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ACAP1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 93 nTPM
Expression across tissuesHPA
Tissue
- spleen: 93 nTPM
- small intestine: 41 nTPM
- bone marrow: 39 nTPM
- lymph node: 37 nTPM
- thymus: 24 nTPM
- tonsil: 21 nTPM
Single-cell type
- late spermatids: 4,047 nCPM
- early spermatids: 363 nCPM
- t-cells: 144 nCPM
- neutrophils: 109 nCPM
- nk-cells: 108 nCPM
- b-cells: 81 nCPM
Immune cell
- T-reg: 39 nTPM
- MAIT T-cell: 33 nTPM
- NK-cell: 33 nTPM
- memory CD8 T-cell: 32 nTPM
- memory CD4 T-cell: 32 nTPM
- eosinophil: 31 nTPM
Brain region
- thalamus: 1.5 nTPM
- cerebral cortex: 1.4 nTPM
- medulla oblongata: 1 nTPM
- pons: 0.9 nTPM
- white matter: 0.9 nTPM
- cerebellum: 0.8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.42
- gnomAD pLI
- 0.07
- gnomAD missense Z
- 2.3
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Arf GTPase activating protein
- Pleckstrin homology domain
- Ankyrin repeat
- BAR domain
- PH-like domain superfamily
- AH/BAR domain superfamily
- Ankyrin repeat-containing domain superfamily
- ARFGAP/RecO-like zinc finger
- ArfGAP domain superfamily
- ArfGAP ACAP1/2/3-like
- PH domain
- Putative GTPase activating protein for Arf
- Ankyrin repeats (3 copies)
- BAR domain of APPL family
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ACAP1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ACAP1 as an antibody target. Whether an autoantibody or antibody against ACAP1 could matter depends on whether native ACAP1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ACAP1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ACAP1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...